Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive intermediate Charcot-Marie-Tooth disease type C is a rare subtype of autosomal recessive intermediate Charcot-Marie-Tooth (CMT) disease characterized by childhood to adulthood-onset of progressive, moderate to severe, predominantly distal, mostly lower limb muscle weakness and atrophy, foot deformities (including pes cavus and hammer toes), absent deep tendon reflexes and distal sensory loss associated with decreased motor and sensory nerve conduction velocities and features of both demyelinating and axonal neuropathy on sural nerve biopsy.
Features include always present findings: Decreased number of large peripheral myelinated nerve fibers, Decreased motor nerve conduction velocity, Sideways curvature of the spine (scoliosis), and Steppage gait and others; and common findings: Hammertoe.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Brain and nerves | 1 | Steppage gait |
Muscles | 1 | Distal muscle weakness |
Lab test results | 1 | Mildly elevated creatine kinase |
PLEKHG5 function has not been fully characterized.
Charcot-Marie-Tooth disease recessive intermediate C is associated with mutations in the PLEKHG5 gene on chromosome 1.
Genetic testing for PLEKHG5 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 11 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Charcot-Marie-Tooth disease recessive intermediate C.
6 publications have been identified in PubMed for Charcot-Marie-Tooth disease recessive intermediate C. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
Vidon RO (2026). [PMID: 41562385](https://pubmed.ncbi.nlm.nih.gov/41562385/). *Journal of the peripheral nervous system : JPNS*. [Case Report / Case Series]
Veh A (2025). [PMID: 41398973](https://pubmed.ncbi.nlm.nih.gov/41398973/). *Translational neurodegeneration*. [Basic Science / Preclinical]
Cortese A (2025). [PMID: 39938083](https://pubmed.ncbi.nlm.nih.gov/39938083/). *Brain : a journal of neurology*. [Epidemiology / Natural History]
Popov IK (2024). [PMID: 39196644](https://pubmed.ncbi.nlm.nih.gov/39196644/). *Molecular biology of the cell*. [Basic Science / Preclinical]
Arlt A (2024). [PMID: 38975976](https://pubmed.ncbi.nlm.nih.gov/38975976/). *Journal of neurogenetics*. [Epidemiology / Natural History]
Wilhelm SDP (2024). [PMID: 39352000](https://pubmed.ncbi.nlm.nih.gov/39352000/). *IUBMB life*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Charcot-Marie-Tooth disease recessive intermediate C